Treatment of esophageal leakages with the Microtech ® -VAC-Stent: a monocentric early experience of three cases
Therapeutic Advances in Gastrointestinal Endoscopy · 2023-01 · 16
DOI: 10.1177/26317745231200312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Gastrointestinal Endoscopy, online erschienen am 28.09.2023. Verfasst von Michelle A Klose und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, Saale, Germany. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Endoscopic approaches in the treatment of transmural esophageal defects, either after esophageal resection or due to perforation, have demonstrated convincing feasibility. Surgical options are limited and associated with high morbidity and mortality rates. Currently, internal endoscopic drainage with pigtail stents, self-expanding metal stent (SEMS), or endoscopic vacuum therapy (EVT) are options for first-line treatment. Here, we report the outcome of the recently developed combination of SEMS and EVT using the endoscopic Microtech ® -VAC-Stent (EVS).
Methods
Between June and July 2022, three consecutive patients (one female and two males) with esophageal transmural defects were treated with the Microtech ® -VAC-Stent. Two patients suffered from an anastomotic leak after oncologic gastroesophageal surgery, and one patient presented with esophageal perforation due to Boerhaave syndrome.
Results
Three consecutive patients were successfully treated with EVS. In one patient, one EVS treatment was sufficient, whereas the other two patients needed two and six EVS exchanges. Exchanges were scheduled every 7 days and no procedural adverse events were observed.
Conclusion
In line with the former case series, EVS therapy is a promising new approach for the treatment of esophageal leaks. Exchange of the EVS seems feasible every 7 days reducing interventions for the individual patient. Prospective studies comparing EVS with other endoscopic therapies are needed to define the best therapeutic approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, Saale, Germany.
- Department of General, Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, Saale, Germany.
- Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06120 Halle, Saale, Germany.
ORCID-Profile: Michelle A Klose, Ulrich Ronellenfitsch, Jonas Rosendahl
Zitieren
APA
Klose, M. A., Walldorf, J., Damm, M., Krug, S., Klose, J., Ronellenfitsch, U., Kleeff, J., Michl, P., & Rosendahl, J. (2023). Treatment of esophageal leakages with the Microtech ® -VAC-Stent: a monocentric early experience of three cases. Therapeutic Advances in Gastrointestinal Endoscopy, 16. https://doi.org/10.1177/26317745231200312
Vancouver
Klose MA, Walldorf J, Damm M, Krug S, Klose J, Ronellenfitsch U, et al. Treatment of esophageal leakages with the Microtech ® -VAC-Stent: a monocentric early experience of three cases. Therapeutic Advances in Gastrointestinal Endoscopy. 2023;16. doi:10.1177/26317745231200312
BibTeX
@article{Klose2023,
author = {Klose, Michelle A and Walldorf, Jens and Damm, Marko and Krug, Sebastian and Klose, Johannes and Ronellenfitsch, Ulrich and Kleeff, Joerg and Michl, Patrick and Rosendahl, Jonas},
title = {Treatment of esophageal leakages with the Microtech ® -VAC-Stent: a monocentric early experience of three cases},
journal = {Therapeutic Advances in Gastrointestinal Endoscopy},
year = {2023},
volume = {16},
doi = {10.1177/26317745231200312}
}
EUVIMED